NEW YORK — Precision medicine firm Tempus said on Monday that it has partnered with the Yale School of Public Health to refine a saliva-based test for SARS-CoV-2.
NEW YORK — Precision medicine firm Tempus said on Monday that it has partnered with the Yale School of Public Health to refine a saliva-based test for SARS-CoV-2.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.